ArticleNeurology and therapy2022

Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study.

Lita Araujo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.